- Antitumor efficacy of NBTXR3 in different types of tumors - in vivo preclinical data- Antitumor efficacy of NBTXR3 when combined with chemotherapy - in vitro and in vivo data

Paris, France and Cambridge, Massachusetts, USA, Mar 7, 2017 - (ACN Newswire) - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine...